Study on the inclusion complex between β-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application

Farmaco

Volumn 60, Issue 6-7, 2005, Pages 575-581

  Manzoori, Jamshid L ^a   Abdolmohammad Zadeh, Hossein ^a   Amjadi, Mohammad ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Celecoxib; Cyclodextrin; Inclusion complex; Spectrofluorimetry

Indexed keywords

BETA CYCLODEXTRIN; CELECOXIB;

AQUEOUS SOLUTION; ARTICLE; CALCULATION; CORRELATION COEFFICIENT; DRUG STRUCTURE; FLUORESCENCE; LINEAR REGRESSION ANALYSIS; MOLECULAR INTERACTION; SPECTROFLUOROMETRY; STANDARDIZATION; STOICHIOMETRY; SUPRAMOLECULAR CHEMISTRY; TEMPERATURE; THERMODYNAMICS;

ALGORITHMS; BETA-CYCLODEXTRINS; FLUORESCENCE; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PYRAZOLES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; SULFONAMIDES; THERMODYNAMICS;

EID: 21944437509     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.02.003     Document Type: Article

References (32)

1. J. Mosinger, V. Tomankova, I. Nemcova, and J. Zyka Cyclodextrins in analytical chemistry Anal. Lett. 34 2001 1979 2004
2. J. Szejtli Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1998 1743 1753
3. J. Szejtli, T. Osa (Eds.). Comprehensive Supramolecular Chemistry, vol. 3, Pergamon, Oxford, 1996.
4. J.L. Manzoori, and M. Amjadi Spectrofluorimetric study of host-guest complexation of ibuprofen with β-cyclodextrin and its analytical application Spectrochim. Acta [A] 59 2003 909 916
5. J.L. Manzoori, and M. Amjadi Spectrofluorimetric and cyclodextrin- enhanced spectrofluorimetric methods for the determination of naphazoline in nasal and eye drops Indian J. Chem. 42A 2003 2988 2992
6. 3 Talanta 53 2001 951 959
7. B. Tang, L. Ma, and C. Ma Spectrofluorimetric study of the β-cyclodextrin-rubidate complex and determination of rubidate by β-CD-enhanced fluorimetry Talanta 58 2002 841 848
8. H.A. Archontaki, M.V. Vertzoni, and M.H. Athanassiou-Malaki Study on the inclusion complexes of bromazepam with β- and β-hydroxypropyl- cyclodextrins J. Pharm. Biomed. Anal. 28 2002 761 769
9. G. Xiliang, Y. Yu, Z. Guoyan, Z. Guomei, C. Jianbin, and S. Shaomin Study on inclusion interaction of piroxicam with β-cyclodextrin derivatives Spectrochim. Acta [A] 59 2003 3379 3386
10. D. Clemett, and K.L. Goa Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain Drugs 59 2000 957 980
11. B.S. Reddy, Y. Hirose, R. Lubet, V. Steele, G. Kelloff, and S. Paulson Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis Cancer Res. 60 2000 293 297
12. P.T. Leese, R.C. Hubbard, A. Karim, P.C. Isakson, S.S. Yu, and G.S. Geis Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial J. Clin. Pharmacol. 40 2000 124 132
13. G. Steinbach, P.M. Lynch, R.K. Phillips, M.H. Wallace, E. Hawk, and G.b. Gordon The effect of Celecoxib, a cyclo-oxygenase inhibitor, in familial adenomatous polyposis N. Engl. J. Med. 342 2000 1946 1952
14. M.K. Srinivasu, D.S. Rao, and G.O. Reddy Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC J. Pharm. Biomed. Anal. 28 2002 493 500
15. R.N. Saha, C. Sajeev, P.R. Jadhav, S.P. Patil, and N. Srinivasan Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography J. Pharm. Biomed. Anal. 28 2002 741 751
16. L.I. Bebawy, A.A. Mostafa, and N.F. Abo-Talib Stability-indicating methods for the determination of doxazosin mezylate and celecoxib J. Pharm. Biomed. Anal. 27 2002 779 793
17. M.M. Ghoneim, and A.M. Beltagi Adsorptive stripping voltammetric determination of the anti-inflammatory drug celecoxib in pharmaceutical formulation and human serum Talanta 60 2003 911 921
18. M.K. Srinivasu, C.L. Narayana, D.S. Rao, and G.O. Reddy A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs J. Pharm. Biomed. Anal. 22 2000 949 956
19. D.S. Rao, M.K. Srinivasu, C.L. Narayana, and G.O. Reddy LC separation of ortho and meta isomers of celecoxib in bulk and formulations using a chiral column J. Pharm. Biomed. Anal. 25 2001 21 30
20. M. Abdel-Hamid, L. Novotny, and H. Hamaz Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics J. Chromatogr. B 753 2001 401 408
21. L. Brautigam, G. Vetter, I. Tegeder, G. Heinkele, and G. Geisslinger Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry J. Chromatogr. B 761 2001 203 212
22. U. Werner, D. Werner, R. Mundkowski, M. Gillich, and K. Brune Selective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans J. Chromatogr. B 760 2001 83 90
23. H.-H.S. Chow, N. Anavy, D. Salazar, D.H. Frank, and D.S. Alberts Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography J. Pharm. Biomed. Anal. 34 2004 167 174
24. H. Jalalzadeh, M. Amini, V. Ziaee, A. Safa, H. Farsam, and A. Shafiee Determination of celecoxib in human plasma by high-performance liquid chromatography J. Pharm. Biomed. Anal. 35 2004 665 670
25. M.J. Rose, E.J. Woolf, and B.K. Matuszewski Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection J. Chromatogr. B 738 2000 377 385
26. E. stormer, S. Bauer, J. Kirchheiner, J. Brockmoller, and I. Roots Simultaneous determination of celecoxib, hydroxycelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detection J. Chromatogr. B 783 2003 207 212
27. F. Schonberger, G. Heinkele, T.E. Murdter, S. Brenner, U. Klotz, and U. Hofmann Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection J. Chromatogr. B 768 2002 255 260
28. G.C. Catena, and F.V. Bright Thermodynamic study on the effects of. beta-cyclodextrin inclusion with anilinonaphthalenesulfonates Anal. Chem. 61 1989 905 909
29. M.V. Rekharsky, and Y. Inoue Complexation Thermodynamics of Cyclodextrins Chem. Rev. 98 1998 1875 1918
30. Y. Inoue, T. Hakushi, Y. Liu, L.H. Tong, B.J. Shen, and D.S. Jin Thermodynamics of molecular recognition by cyclodextrins. 1. Calorimetric titration of inclusion complexation of naphthalenesulfonates with. alpha-, beta-, and gamma-cyclodextrins: enthalpy-entropy compensation J. Am. Chem. Soc. 115 1993 475 481
31. M.R. Eftink, M.L. Andy, K. Bystrom, H.D. Permutter, and D.S. Kristol Cyclodextrin inclusion complexes: studies of the variation in the size of alicyclic guests J. Am. Chem. Soc. 111 1989 6765 6772
32. J.C. Miller, J.N. Miller (Eds.). Statistics for Analytical Chemistry, second ed, Ellis Horwood, Chichester, 1988, pp. 55-58.